Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) Debt-to-Equity : 0.03 (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Beijing Tong Ren Tang Chinese Medicine Co Debt-to-Equity?

Beijing Tong Ren Tang Chinese Medicine Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$56 Mil. Beijing Tong Ren Tang Chinese Medicine Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$75 Mil. Beijing Tong Ren Tang Chinese Medicine Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$3,867 Mil. Beijing Tong Ren Tang Chinese Medicine Co's debt to equity for the quarter that ended in Dec. 2023 was 0.03.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Beijing Tong Ren Tang Chinese Medicine Co's Debt-to-Equity or its related term are showing as below:

HKSE:03613' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.03 Med: 0.04 Max: 0.04
Current: 0.03

During the past 13 years, the highest Debt-to-Equity Ratio of Beijing Tong Ren Tang Chinese Medicine Co was 0.04. The lowest was 0.03. And the median was 0.04.

HKSE:03613's Debt-to-Equity is ranked better than
89.19% of 851 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs HKSE:03613: 0.03

Beijing Tong Ren Tang Chinese Medicine Co Debt-to-Equity Historical Data

The historical data trend for Beijing Tong Ren Tang Chinese Medicine Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tong Ren Tang Chinese Medicine Co Debt-to-Equity Chart

Beijing Tong Ren Tang Chinese Medicine Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.04

0.03

Beijing Tong Ren Tang Chinese Medicine Co Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.04	0.03	0.03	0.04	0.03

Competitive Comparison of Beijing Tong Ren Tang Chinese Medicine Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Tong Ren Tang Chinese Medicine Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Tong Ren Tang Chinese Medicine Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Tong Ren Tang Chinese Medicine Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Beijing Tong Ren Tang Chinese Medicine Co's Debt-to-Equity falls into.

Beijing Tong Ren Tang Chinese Medicine Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Beijing Tong Ren Tang Chinese Medicine Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(56.42	+	75.393)	/	3866.513
	=	0.03

Beijing Tong Ren Tang Chinese Medicine Co's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(56.42	+	75.393)	/	3866.513
	=	0.03

Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Beijing Tong Ren Tang Chinese Medicine Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Beijing Tong Ren Tang Chinese Medicine Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Tong Ren Tang Chinese Medicine Co Ltd (HKSE:03613) » Definitions » Debt-to-Equity

Traded in Other Exchanges

TQR:Germany

Address

Convention Plaza, 1 Harbour Road, Room 1405-1409, Office Tower, Wanchai, Hong Kong, HKG

Website

https://cm.tongrentang.com

Beijing Tong Ren Tang Chinese Medicine Co Ltd is a pharmaceutical retailer that specializes in Chinese medicine operating in three segments; Hong Kong includes the sale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments through retail and wholesale of Chinese medicine products and healthcare products, Mainland China (PRC, but excluding Hong Kong, Macao, and Taiwan) includes wholesale of healthcare products in Mainland China and the sole distributor of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd, and Overseas includes retail and wholesale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments.

Beijing Tong Ren Tang Chinese Medicine Co (HKSE:03613) Headlines

No Headlines